Niquitin Extra Fresh Mint (Nicotine Resinate)

Nicotine resinate, the active ingredient in Niquitin Extra Fresh Mint, is a nicotinic agonist presented as an oral mucosal formulation for oromucosal use. It is employed to aid smoking cessation in adults who wish to reduce nicotine dependence and manage withdrawal symptoms.

GNH USA supplies Niquitin Extra Fresh Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine resinate is used as a smoking cessation aid that targets nicotine dependence.

- Smoking cessation: helps reduce cravings and withdrawal symptoms during quit attempts. - Nicotine dependence: supports gradual reduction of nicotine intake for adults. - Relapse prevention: assists individuals in maintaining abstinence after quitting.

Adverse reactions may occur with oromucosal nicotine products.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: transient discomfort or scratchy sensation. - Nausea: occasional upset stomach. - Hiccups: brief episodes following use. - Dizziness: light‑headed feeling, especially in sensitive individuals. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Severe mouth ulceration: persistent lesions requiring medical attention. - Cardiovascular events: chest pain, palpitations, or hypertension spikes. - Respiratory distress: shortness of breath or wheezing. - Seizures: rare but reported in cases of overdose. - Unexplained fainting: sudden loss of consciousness.

Before using Niquitin Extra Fresh Mint, consider the following safety measures.

- Cardiovascular assessment: evaluate heart disease or uncontrolled hypertension before initiation. - Pregnancy and lactation: avoid use unless benefits outweigh potential risks; consult a healthcare professional. - Allergy screening: discontinue if signs of hypersensitivity appear. - Dosage adherence: follow prescriber instructions and avoid concurrent nicotine products. - Child safety: keep out of reach of children and pets. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nicotine resinate may interact with other medicines; monitor the following.

Major Interactions (Avoid): - Concurrent nicotine replacement therapies: risk of nicotine overdose. - Bupropion or other seizure‑threshold‑lowering agents: increased seizure risk.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., certain antivirals): may alter nicotine metabolism. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Antihypertensives: additive blood‑pressure‑lowering effects. - MAO‑inhibitors: potential for enhanced sympathomimetic activity. - Caffeine‑containing products: may increase stimulant effects.